Lab Meeting


発表グループ 抄読会担当者 開始時間 場所
6日(月) 祝日
13日(月) C


16:00~ E棟300室
20日(月) A


16:00~ E棟300室
27日(月) B
村田 16:00~ E棟300室


発表グループ 抄読会担当者 開始時間 場所
1日(月) C


16:00~ E棟300室
8日(月) A


16:00~ E棟300室
22日(月) B


16:00~ E棟300室
29日(月) 昭和の日


発表グループ 抄読会担当者 開始時間 場所
11日(月) A


16:00~ E棟300室
18日(月) B


16:00~ E棟300室
25日(月) C


16:00~ E棟300室


発表グループ 抄読会担当者 開始時間 場所
4日(月) C 坂本 16:00~ E棟300室
11日(月) 建国記念の日 
18日(月) A  中川 16:00~ E棟300室
25日(月) D  河合 16:00~ E棟300室


発表グループ 抄読会担当者 開始時間 場所
7日(月) D 16:00~ E棟300室
14日(月) 成人の日 
21日(月) A  佐藤 16:00~ E棟300室
28日(月) B  Ryan 16:00~ E棟300室


発表グループ 抄読会担当者 開始時間 場所
3日(月) レトリーブ 9:00~ E棟 300室


発表グループ 抄読会担当者 開始時間 場所
5日(月) A


16:00~ E棟300室
12日(月) B



16:00~ E棟300室
26日(月) C






発表グループ 抄読会担当者 開始時間 場所
1日(月) A 村田 16:00~ E棟300室
8日(月) 体育の日





22日(月) C


16:00~ E棟300室
29日(月) D  Zeina




発表グループ 抄読会担当者 開始時間 場所
3日(月) D



16:00~ E棟300室
10日(月) C



16:00~ E棟300室
17日(月) 敬老の日



発表グループ 抄読会担当者 開始時間 場所
2日(月) D Kim 16:00~ E棟300室
9日(月) C 大和 17:00~ E棟300室
16日(月) 海の日
23日(月) A  坂下(麻) 16:00~ E棟300室
30日(月) B  柴 16:00~ E棟300室


発表グループ 抄読会担当者 開始時間 場所
4日(月) C



16:45~ E棟300室
11日(月) D



16:00~ E棟300室
18日(月) A 松岡 16:00~ E棟300室
25日(月) B



16:00~ E棟300室


発表グループ 抄読会担当者 開始時間 場所
7日(月) C 坂本 16:00~ E棟300室
14日(月) D



16:00~ E棟300室
21日(月) A 中野 16:00~ E棟300室
28日(月) B



16:00~ E棟300室


発表グループ 抄読会担当者 開始時間 場所
2日(月) C 村田 16:00~ E棟300室
9日(月) D Ryan 16:00~ E棟300室
16日(月) A 坂下 16:00~ E棟300室
23日(月) B  加野 16:30~ E棟300室
30日(月) 昭和の日 振替休日



4/8/2019 matsuoka Clot G, Jares P, Giné E, Navarro A, Royo C, Pinyol M, Martín-Garcia D, Demajo S, Espinet B, Salar A, Ferrer A, Muntañola A, Aymerich M, Rauert-Wunderlich H, Jaffe ES, Connors JM, Gascoyne RD, Delabie J, López-Guillermo A, Ott G, Wright GW, Staudt LM, Rosenwald A, Scott DW, Rimsza LM, Beà S, Campo E. A gene signature that distinguishes conventional and leukemic nonnodal mantle cell lymphoma helps predict outcome. Blood. 2018 Jul 26;132(4):413-422. Epub 2018 May 16. PMID: 29769262
4/1/2019 Zeina Fokkelman M, Balcıoğlu HE, Klip JE, Yan K, Verbeek FJ, Danen EH, van de Water B. Cellular adhesome screen identifies critical modulators of focal adhesion dynamics, cellular traction forces and cell migration behaviour. Sci Rep. 2016 Aug 17;6:31707. PMID: 27531518


3/11/2019 Sakamoto Gao YF, Zhu T, Chen J, Liu L, Ouyang R. Knockdown of collagen α-1(III) inhibits glioma cell proliferation and migration and is regulated by miR128-3p. Oncol Lett. 2018 Aug;16(2):1917-1923.  PMID: 30008884


2/25/2019 Kawai Shim HS, Kenudson M, Zheng Z, Liebers M, Cha YJ, Hoang Ho Q, Onozato M, Phi Le L, Heist RS, Iafrate AJ. Unique Genetic and Survival Characteristics of Invasive Mucinous Adenocarcinoma of the Lung. J Thorac Oncol. 2015 Aug;10(8):1156-62. PMID: 26200269
2/18/2019 Nakagawa Geng Y, Liu X, Liang J, Habiel DM, Vrishika K, Coelho AL, Deng N, Xie T, Wang Y, Liu N, Huang G, Kurkciyan A, Liu Z, Tang J, Hogaboam CM, Jiang D, Noble PW. PD-L1 on invasive fibroblasts drives fibrosis in a humanized model of idiopathic pulmonary fibrosis. JCI Insight. 2019 Feb 14. PMID: 30763282


1/21/2019 Sato Inaga S, Hirashima S, Tanaka K, Katsumoto T, Kameie T, Nakane H, Naguro T. Low vacuum scanning electron microscopy for paraffin sections utilizing the differential stainability of cells and tissues with platinum blue.Arch Histol Cytol. 2009 Jul;72(2):101-6.
PMID: 20009346
1/7/2019 Dai Yamaguchi T, Lu C, Ida L, Yanagisawa K, Usukura J, Cheng J, Hotta N, Shimada Y, Isomura H, Suzuki M, Fujimoto T, Takahashi T. ROR1 sustains caveolae and survival signalling as a scaffold of cavin-1 and caveolin-1. Nat Commun.2016 Jan 4.
PMID: 26725982


11/5/2018 Sakashita Lakshmanan I, Salfity S, Seshacharyulu P, Rachagani S, Thomas A, Das S, Majhi PD, Nimmakayala RK, Vengoji R, Lele SM, Ponnusamy MP, Batra SK, Ganti AK  MUC16 Regulates TSPYL5 for Lung Cancer Cell Growth and Chemoresistance by Suppressing p53. Clin Cancer Res. 2017 Jul 15;23(14):3906-3917.  Epub 2017 Feb 14.
PMID: 28196872


10/29/2018 Zeina Justilien V, Ali SA, Jamieson L, Yin N, Cox AD, Der CJ, Murray NR1 Fields AP.  Ect2-Dependent rRNA Synthesis Is Required for KRAS-TRP53-Driven Lung Adenocarcinoma. Cancer Cell. 2017 Feb 13;31(2):256-269.
PMID: 28110998
10/15/2018 Hong Rehman J, Zhang HJ, Toth PT, Zhang Y, Marsboom G, Hong Z, Salgia R, Husain AN, Wietholt C, Archer SL. Inhibition of mitochondrial fission prevents cell cycle progression in lung cancer. FASEB J. 2012 May;26(5):2175-86.  Epub 2012 Feb 9. 
PMID: 22321727
10/1/2018 Murata Zhou S, Wang P, Su X, Chen J, Chen H, Yang H, Fang A, Xie L, Yao Y, Yang J. High ECT2 expression is an independent prognostic factor for poor overall survival and recurrence-free survival in non-small cell lung adenocarcinoma. PLoS One. 2017 Oct 31;12(10):e0187356.   PLoS One. 2018 Apr 19;13(4):e0196354.
PMID: 29088286


7/23/2018 Mai Sakashita Sinha S, Bheemsetty VA, Inamdar MS. A double helical motif in OCIAD2 is essential for its localization, interactions and STAT3 activation. Sci Rep. 2018 May 9;8(1):7362.
PMID: 29743632
7/9/2018 Yamato Qiu FN, Huang Y, Chen DY, Li F, Wu YA, Wu WB, Huang XL  Eukaryotic elongation factor-1α 2 knockdown inhibits hepatocarcinogenesis by suppressing PI3K/Akt/NF-κB signaling. World J Gastroenterol. 2016 Apr 28;22(16):4226-37.
PMID: 27122673
7/2/2018 Kim Rizvi NA, Hellmann MD, Snyder A, Kvistborg P, Makarov V, Havel JJ, Lee W, Yuan J, Wong P, Ho TS, Miller ML, Rekhtman N, Moreira AL, Ibrahim F, Bruggeman C, Gasmi B, Zappasodi R, Maeda Y, Sander C, Garon EB, Merghoub T, Wolchok JD, Schumacher TN, Chan TA. Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer. Science. 2015 Apr 3;348(6230):124-8.
PMID: 25765070
2018June 6/18/2018 matsuoka Shimada K, Shimada S, Sugimoto K, Nakatochi M, Suguro M, Hirakawa A, Hocking TD, Takeuchi I, Tokunaga T, Takagi Y, Sakamoto A, Aoki T, Naoe T, Nakamura S, Hayakawa F, Seto M, Tomita A, Kiyoi H. Development and analysis of patient-derived xenograft mouse models in intravascular large B-cell lymphoma. Leukemia. 2016 Jul;30(7):1568-79.PMID: 27001523


5/21/2018 Nakano Niemas-Teshiba R, Matsuno R, Wang LL, Tang XX, Chiu B, Zeki J, Coburn J, Ornell K, Naranjo A, Van Ryn C, London WB, Hogarty MD, Gastier-Foster JM, Look AT, Park JR, Maris JM, Cohn SL, Seeger RC, Asgharzadeh S, Ikegaki N, Shimada H. MYC-family protein overexpression and prominent nucleolar formation represent prognostic indicators and potential therapeutic targets for aggressive high-MKI neuroblastomas: a report from the children's oncology group. Oncotarget. 2017 Dec 15;9(5):6416-6432
PMID: 29464082
5/7/2018 Sakamoto Mount CW, Majzner RG, Sundaresh S, Arnold EP, Kadapakkam M4 Haile S, Labanieh L,Hulleman E, Woo PJ, Rietberg SP, Vogel H, Monje M, Mackall CL. Potent antitumor efficacy of anti-GD2 CAR T cells in H3-K27M+ diffuse midline gliomas. Nat Med. 2018 May;24(5):572-579.
PMID: 29662203


4/23/2018 Kano Cohen JD, Li L, Wang Y, Thoburn C, Afsari B, Danilova L, Douville C, Javed AA, Wong F, Mattox A, Hruban RH, Wolfgang CL, Goggins MG, Dal Molin M, Wang TL, Roden R, Klein AP, Ptak J, Dobbyn L1, Schaefer J, Silliman N, Popoli M, Vogelstein JT, Browne JD, Schoen RE, Brand RE, Tie J, Gibbs P, Wong HL, Mansfield AS, Jen J, Hanash SM, Falconi M, Allen PJ, Zhou S1, Bettegowda C, Diaz LA Jr., Tomasetti C, Kinzler KW, Vogelstein B, Lennon AM, Papadopoulos N . Detection and localization of surgically resectable cancers with a multi-analyte blood test. Feb 23;359(6378):926-930.. Epub 2018 Jan 18.
PMID: 29348365


Sakashita Sesma JI, Kreda SM, Okada SF, van Heusden C, Moussa L, Jones LC, O'Neal WK, Togawa N, Hiasa M, Moriyama Y, Lazarowski ER. Vesicular nucleotide transporter regulates the nucleotide content in airway epithelial mucin granules. AmJ Physiol Cell Physiol. 2013 May 15;304(10):C976-84.
PMID: 23467297
4/9/2018 Ryan Fujii S, Yamashita S, Yamaguchi T, Takahashi M, Hozumi Y, Ushijima T, Mukai H. Pathological complete response of HER2-positive breast cancer to trastuzumab and chemotherapy can be predicted by HSD17B4 methylation. Oncotarget. 2017 Mar 21;8(12):19039-19048.
PMID: 28186977
4/2/2018 Murata Yamaguchi N, Mizutani T, Kawabata K, Haga H. Leader cells regulate collective cell migration via Rac activation in the downstream signaling of integrin β1 and PI3K. Sci Rep. 2015 Jan 7;5:7656..br />PMID: 25563751


3/12/2018 Sugiyama van Boerdonk RA, Sutedja TG, Snijders PJ, Reinen E, Wilting SM, van de Wiel MA, Thunnissen FE, Duin S, Kooi C, Ylstra B, Meijer CJ, Meijer GA, Grünberg K, Daniels JM, Postmus PE, Smit EF, Heideman DA. DNA copy number alterations in endobronchial squamous metaplastic lesions predict lung cancer.Am J Respir Crit Care Med. 2011 Oct 15;184(8):948-56.
PMID: 21799074
3/5/2018 Nakagawa Calvo F, Sanz-Moreno V, Agudo-Ibáñez L, Wallberg F, Sahai E, Marshall CJ, Crespo RasGRF suppresses Cdc42-mediated tumour cell movement, cytoskeletal dynamics and transformation. P.Nat Cell Biol. 2011 Jun 19;13(7):819-26.
PMID: 21685891
2018Feb 2/5/2018 Dai Wang Y, Zhou Y, Tao F, Chai S, Xu X, Yang Y, Yang Y, Xu H, Wang K.  N-myc downstream regulated gene 1(NDRG1) promotes the stem-like properties of lung cancer cells through stabilized c-Myc. Cancer Lett. 2017 Aug 10;401:53-62.. Epub 2017 Apr 27. PMID: 28456659
2018Jan 1/29/2018 Matsuoka Lee JK1 Lee J, Kim S, Kim S, Youk J, Park S, An Y, Keam B, Kim DW, Heo DS, Kim YT Kim JS, Kim SH, Lee JS, Lee SH, Park K, Ku JL, Jeon YK, Chung DH, Park PJ, Kim J, Kim TM, Ju YS.J  Clonal History and Genetic Predictors of Transformation Into Small-Cell Carcinomas From Lung Adenocarcinomas. Clin Oncol. 2017 Sep 10;35(26):3065-3074. Epub 2017 May 12. PMID: 28498782
2017Dec 12/4/2017 Kano Federico G, Meister M, Mathow D, Heine GH, Moldenhauer G, Popovic ZV, Nordström V, Kopp-Schneider A, Hielscher T, Nelson PJ, Schaefer F, Porubsky S, Fliser D, Arnold B, Gröne HJ. Tubular Dickkopf-3 promotes the development of renal atrophy and fibrosis.JCI Insight. 2016 Jan 21;1(1):e84916.PMID: 27699213
2017Nov 11/20/2017 Yano De Paoli-Iseppi R1, Johansson PA2, Menzies AM3, Dias KR4, Pupo GM5, Kakavand H6, Wilmott JS7, Mann GJ8, Hayward NK2, Dinger ME4, Long GV3, Scolyer RA9.Comparison of whole-exome sequencing of matched fresh and formalin fixed paraffin embedded melanoma tumours: implications for clinical decision making. Pathology. 2016 Apr;48(3):261-6. PMID: 27020503


Shiba Kamerkar S1, LeBleu VS1, Sugimoto H1, Yang S1, Ruivo CF2, Melo SA1,2, Lee JJ3, Kalluri R1. Exosomes facilitate therapeutic targeting of oncogenic KRAS in pancreatic cancer.Nature. 2017 Jun 22;546(7659):498-503. PMID: 28607485


Nakano Matsubara D, Soda M, Yoshimoto T, Amano Y, Sakuma Y, Yamato A, Ueno T, Kojima S, Shibano T, Hosono Y, Kawazu M, Yamashita Y, Endo S, Hagiwara K, Fukayama M, Takahashi T, Mano H, Niki T. Inactivating mutations and hypermethylation of the NKX2-1/TTF-1 gene in non-terminal respiratory unit-type lung adenocarcinomas. Cancer Sci. 2017 Sep;108(9):1888-1896. Epub 2017 Jul 29. PMID: 28677170
  2017July 7/31/2017 Sakamoto Kohanbash G, Carrera DA, Shrivastav S, Ahn BJ, Jahan N, Mazor T, Chheda ZS, Downey KM, Watchmaker PB, Beppler C, Warta R, Amankulor NA, Herold-Mende C, Costello JF, Okada H. Isocitrate dehydrogenase mutations suppress STAT1 and CD8+ T cell accumulation in gliomas.J Clin Invest. 2017 Apr 3;127(4):1425-1437. PMID: 28319047 Free PMC Article


Hong Raychaudhuri K, Chaudhary N, Gurjar M, D'Souza R, Limzerwala J, Maddika S, Dalal SN.14-3-3σ Gene Loss Leads to Activation of the Epithelial to Mesenchymal Transition Due to the Stabilization of c-Jun Protein.J Biol Chem. 2016 Jul 29;291(31):16068-81. PMID: 27261462
2017June 6/26/2017 Sato Tsuruta T, Kozaki K, Uesugi A, Furuta M, Hirasawa A, Imoto I, Susumu N, Aoki D, Inazawa J.miR-152 is a tumor suppressor microRNA that is silenced by DNA hypermethylation in endometrial cancer.Cancer Res. 2011 Oct 15;71(20):6450-62. PMID: 21868754 Free Article
2017May  5/15/2017 Komori Lorsy E, Topuz AS, Geisler C, Stahl S, Garczyk S, von Stillfried S, Hoss M, Gluz O, Hartmann A, Knüchel R, Dahl E. Loss of Dickkopf 3 Promotes the Tumorigenesis of Basal Breast Cancer. PLoS One. 2016 Jul 28;11(7):e0160077. PMID: 27467270 Free PMC Article


Sakashita Gu Y, Shea J, Slattum G, Firpo MA, Alexander M, Mulvihill SJ, Golubovskaya VM, Rosenblatt J. Defective apical extrusion signaling contributes to aggressive tumor hallmarks. Elife. 2015 Jan 26;4:e04069. PMID: 25621765
2017April 4/24/2017 Murata Chen CJ, Sung WW, Chen HC, Chern YJ, Hsu HT, Lin YM, Lin SH, Peck K, Yeh KT. Int J Mol  Early Assessment of Colorectal Cancer by Quantifying Circulating Tumor Cells in Peripheral Blood: ECT2 in Diagnosis of Colorectal Cancer. Sci. 2017 Mar 31;18(4). pii: E743. PMID: 28362321
Page Top